The demineralized bone matrix market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to limited availability of allograft bone materials, reliance on conventional bone grafts, increasing orthopedic and dental procedures, growing awareness of bone healing solutions, adoption of standard surgical practices.
The demineralized bone matrix market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to innovation in bioactive gels and collagen matrices, rising spinal fusion and joint reconstruction surgeries, expansion of specialty clinics and ambulatory surgical centers, increasing regulatory approvals and quality certifications, integration of minimally invasive surgical techniques. Major trends in the forecast period include rising adoption of demineralized bone matrix in orthopedic surgeries, increased use in dental and craniomaxillofacial procedures, growth in spinal fusion and long bone reconstruction applications, development of injectable and thermosensitive gel products, focus on collagen-based and bioactive bone regeneration materials.
The rising prevalence of orthopedic disorders is expected to drive the growth of the demineralized bone matrix (DBM) market in the coming years. Orthopedic disorders encompass conditions affecting the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. The demand for orthopedic treatments is growing due to the aging global population, as older adults are more susceptible to musculoskeletal conditions such as osteoarthritis, osteoporosis, and fractures. Demineralized bone matrix supports orthopedic care by promoting bone regeneration and healing, making it a vital component in spinal fusion, joint reconstruction, and fracture repair. It enhances recovery by providing an osteoinductive scaffold that encourages natural bone growth and improves surgical outcomes. For example, in August 2023, a survey by the Institute for Health Metrics and Evaluation, a US-based public health research organization, reported that 15% of individuals aged 30 and above had osteoarthritis in 2023, with the number expected to reach approximately 1 billion by 2050. Thus, the increasing prevalence of orthopedic disorders is fueling growth in the DBM market.
Major companies operating in the demineralized bone matrix market are emphasizing innovative advancements such as flowable demineralized fibers to improve graft handling, enhance osteoinductive properties, and increase surgical efficiency. Flowable demineralized fibers are moldable demineralized bone matrix materials made from cortical bone fibers suspended in a carrier, enabling easier placement and supporting natural bone regeneration. For example, in January 2025, LifeNet Health, Inc., a U.S.-based non-profit organization, introduced PliaFX Flo, a solution designed to improve bone graft handling, placement accuracy, and fusion outcomes. PliaFX Flo features a flowable, carrier-free demineralized fiber technology that enhances graft moldability and ease of placement during bone fusion procedures. The product delivers a dense fiber network intended to maximize natural osteoinductive potential and optimize handling in complex anatomical environments.
In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. for an undisclosed sum. Through this merger, Globus Medical seeks to strengthen its leadership position in the global spine and orthopedics market by incorporating NuVasive’s expertise in minimally invasive surgical techniques and advanced intraoperative technologies. NuVasive Inc., also based in the US, manufactures demineralized bone matrix (DBM) products under its Propel DBM brand.
Major companies operating in the demineralized bone matrix market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Arthrex Inc, Straumann AG, Globus Medical Inc, Integra LifeSciences Corporation, MTF Biologics, Exactech Inc, RTI Surgical, AlloSource, Cerapedics Inc, Keystone Dental Inc, Xtant Medical Holdings Inc, Hans Biomed Co Ltd, Bone Biologics Corp, SeaSpine Holdings Corporation, Orthofix Medical Inc, LifeNet Health.
North America was the largest region in the demineralized bone matrix market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the demineralized bone matrix market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the demineralized bone matrix market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the demineralized bone matrix market by increasing the cost of imported raw materials and allograft bone products. Segments such as gel, putty, and collagen-based sponges are particularly impacted, with regions like North America and Asia-Pacific facing import duties that raise production and procurement costs. While tariffs create short-term supply chain challenges and price fluctuations, they also encourage local sourcing, domestic manufacturing, and innovation in advanced bone regeneration products, fostering long-term market resilience.
The demineralized bone matrix market research report is one of a series of new reports that provides demineralized bone matrix market statistics, including demineralized bone matrix industry global market size, regional shares, competitors with a demineralized bone matrix market share, detailed demineralized bone matrix market segments, market trends and opportunities, and any further data you may need to thrive in the demineralized bone matrix industry. This demineralized bone matrix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Demineralized bone matrix (DBM) is an allograft bone product created by removing the mineral content from human bone, leaving the organic collagen matrix and growth factors intact. This process retains proteins such as bone morphogenetic proteins (BMPs), which aid in promoting new bone growth. DBM is widely used in orthopedic and dental surgeries to facilitate bone healing and regeneration.
The main types of demineralized bone matrix products include gel, putty, sponge, fiber, paste, and others. Gel DBM is a formulation where the demineralized bone matrix is suspended in a biocompatible carrier like glycerol, hyaluronic acid, or saline-based solutions, resulting in a moldable and injectable gel-like texture. The tissue sources for DBM include allograft and xenograft materials, and it is utilized in various medical procedures such as dental, craniomaxillofacial, spinal fusion, long bone surgeries, joint reconstruction, and more. The key end users are hospitals, ambulatory surgical centers, specialty clinics, and others.
The demineralized bone matrix market consists of sales of puros demineralized bone matrix, bio-demineralized bone matrix (DBM), evograft, demineralized bone matrix chips, and demineralized bone matrix sheets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The demineralized bone matrix market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to innovation in bioactive gels and collagen matrices, rising spinal fusion and joint reconstruction surgeries, expansion of specialty clinics and ambulatory surgical centers, increasing regulatory approvals and quality certifications, integration of minimally invasive surgical techniques. Major trends in the forecast period include rising adoption of demineralized bone matrix in orthopedic surgeries, increased use in dental and craniomaxillofacial procedures, growth in spinal fusion and long bone reconstruction applications, development of injectable and thermosensitive gel products, focus on collagen-based and bioactive bone regeneration materials.
The rising prevalence of orthopedic disorders is expected to drive the growth of the demineralized bone matrix (DBM) market in the coming years. Orthopedic disorders encompass conditions affecting the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. The demand for orthopedic treatments is growing due to the aging global population, as older adults are more susceptible to musculoskeletal conditions such as osteoarthritis, osteoporosis, and fractures. Demineralized bone matrix supports orthopedic care by promoting bone regeneration and healing, making it a vital component in spinal fusion, joint reconstruction, and fracture repair. It enhances recovery by providing an osteoinductive scaffold that encourages natural bone growth and improves surgical outcomes. For example, in August 2023, a survey by the Institute for Health Metrics and Evaluation, a US-based public health research organization, reported that 15% of individuals aged 30 and above had osteoarthritis in 2023, with the number expected to reach approximately 1 billion by 2050. Thus, the increasing prevalence of orthopedic disorders is fueling growth in the DBM market.
Major companies operating in the demineralized bone matrix market are emphasizing innovative advancements such as flowable demineralized fibers to improve graft handling, enhance osteoinductive properties, and increase surgical efficiency. Flowable demineralized fibers are moldable demineralized bone matrix materials made from cortical bone fibers suspended in a carrier, enabling easier placement and supporting natural bone regeneration. For example, in January 2025, LifeNet Health, Inc., a U.S.-based non-profit organization, introduced PliaFX Flo, a solution designed to improve bone graft handling, placement accuracy, and fusion outcomes. PliaFX Flo features a flowable, carrier-free demineralized fiber technology that enhances graft moldability and ease of placement during bone fusion procedures. The product delivers a dense fiber network intended to maximize natural osteoinductive potential and optimize handling in complex anatomical environments.
In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. for an undisclosed sum. Through this merger, Globus Medical seeks to strengthen its leadership position in the global spine and orthopedics market by incorporating NuVasive’s expertise in minimally invasive surgical techniques and advanced intraoperative technologies. NuVasive Inc., also based in the US, manufactures demineralized bone matrix (DBM) products under its Propel DBM brand.
Major companies operating in the demineralized bone matrix market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Arthrex Inc, Straumann AG, Globus Medical Inc, Integra LifeSciences Corporation, MTF Biologics, Exactech Inc, RTI Surgical, AlloSource, Cerapedics Inc, Keystone Dental Inc, Xtant Medical Holdings Inc, Hans Biomed Co Ltd, Bone Biologics Corp, SeaSpine Holdings Corporation, Orthofix Medical Inc, LifeNet Health.
North America was the largest region in the demineralized bone matrix market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the demineralized bone matrix market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the demineralized bone matrix market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the demineralized bone matrix market by increasing the cost of imported raw materials and allograft bone products. Segments such as gel, putty, and collagen-based sponges are particularly impacted, with regions like North America and Asia-Pacific facing import duties that raise production and procurement costs. While tariffs create short-term supply chain challenges and price fluctuations, they also encourage local sourcing, domestic manufacturing, and innovation in advanced bone regeneration products, fostering long-term market resilience.
The demineralized bone matrix market research report is one of a series of new reports that provides demineralized bone matrix market statistics, including demineralized bone matrix industry global market size, regional shares, competitors with a demineralized bone matrix market share, detailed demineralized bone matrix market segments, market trends and opportunities, and any further data you may need to thrive in the demineralized bone matrix industry. This demineralized bone matrix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Demineralized bone matrix (DBM) is an allograft bone product created by removing the mineral content from human bone, leaving the organic collagen matrix and growth factors intact. This process retains proteins such as bone morphogenetic proteins (BMPs), which aid in promoting new bone growth. DBM is widely used in orthopedic and dental surgeries to facilitate bone healing and regeneration.
The main types of demineralized bone matrix products include gel, putty, sponge, fiber, paste, and others. Gel DBM is a formulation where the demineralized bone matrix is suspended in a biocompatible carrier like glycerol, hyaluronic acid, or saline-based solutions, resulting in a moldable and injectable gel-like texture. The tissue sources for DBM include allograft and xenograft materials, and it is utilized in various medical procedures such as dental, craniomaxillofacial, spinal fusion, long bone surgeries, joint reconstruction, and more. The key end users are hospitals, ambulatory surgical centers, specialty clinics, and others.
The demineralized bone matrix market consists of sales of puros demineralized bone matrix, bio-demineralized bone matrix (DBM), evograft, demineralized bone matrix chips, and demineralized bone matrix sheets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Demineralized Bone Matrix Market Characteristics
3. Demineralized Bone Matrix Market Supply Chain Analysis
4. Global Demineralized Bone Matrix Market Trends and Strategies
5. Demineralized Bone Matrix Market Analysis of End Use Industries
7. Global Demineralized Bone Matrix Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Demineralized Bone Matrix Total Addressable Market (TAM) Analysis for the Market
9. Demineralized Bone Matrix Market Segmentation
10. Demineralized Bone Matrix Market Regional and Country Analysis
11. Asia-Pacific Demineralized Bone Matrix Market
12. China Demineralized Bone Matrix Market
13. India Demineralized Bone Matrix Market
14. Japan Demineralized Bone Matrix Market
15. Australia Demineralized Bone Matrix Market
16. Indonesia Demineralized Bone Matrix Market
17. South Korea Demineralized Bone Matrix Market
18. Taiwan Demineralized Bone Matrix Market
19. South East Asia Demineralized Bone Matrix Market
20. Western Europe Demineralized Bone Matrix Market
21. UK Demineralized Bone Matrix Market
22. Germany Demineralized Bone Matrix Market
23. France Demineralized Bone Matrix Market
24. Italy Demineralized Bone Matrix Market
25. Spain Demineralized Bone Matrix Market
26. Eastern Europe Demineralized Bone Matrix Market
27. Russia Demineralized Bone Matrix Market
28. North America Demineralized Bone Matrix Market
29. USA Demineralized Bone Matrix Market
30. Canada Demineralized Bone Matrix Market
31. South America Demineralized Bone Matrix Market
32. Brazil Demineralized Bone Matrix Market
33. Middle East Demineralized Bone Matrix Market
34. Africa Demineralized Bone Matrix Market
36. Demineralized Bone Matrix Market Competitive Landscape and Company Profiles
37. Demineralized Bone Matrix Market Other Major and Innovative Companies
40. Demineralized Bone Matrix Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Demineralized Bone Matrix Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses demineralized bone matrix market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for demineralized bone matrix? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The demineralized bone matrix market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Gel; Putty; Sponge; Fiber; Paste; Other Product Types2) By Tissue Source: Allograft; Synthetic Bone Graft Substitutes
3) By Application: Dental; Craniomaxillofacial; Spinal Fusion; Long Bone Procedures; Joint Reconstruction; Other Applications
4) By End-Use: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Uses
Subsegments:
1) By Gel: Injectable Gel; Bioactive Gel; Thermosensitive Gel2) By Putty: Moldable Putty; Radiopaque Putty; Self-Setting Putty
3) By Sponge: Resorbable Sponge; Collagen-Based Sponge; Porous Sponge
4) By Fiber: Mineralized Fiber; Non-Mineralized Fiber; Collagen Fiber Matrix
5) By Paste: Flowable Paste; Adhesive Paste; Viscous Paste
6) By Other Product Types: Sheet Matrix; Strip Matrix; Granules
Companies Mentioned: Johnson and Johnson; Medtronic plc; Stryker Corporation; Zimmer Biomet Holdings Inc; Arthrex Inc; Straumann AG; Globus Medical Inc; Integra LifeSciences Corporation; MTF Biologics; Exactech Inc; RTI Surgical; AlloSource; Cerapedics Inc; Keystone Dental Inc; Xtant Medical Holdings Inc; Hans Biomed Co Ltd; Bone Biologics Corp; SeaSpine Holdings Corporation; Orthofix Medical Inc; LifeNet Health
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Demineralized Bone Matrix market report include:- Johnson and Johnson
- Medtronic plc
- Stryker Corporation
- Zimmer Biomet Holdings Inc
- Arthrex Inc
- Straumann AG
- Globus Medical Inc
- Integra LifeSciences Corporation
- MTF Biologics
- Exactech Inc
- RTI Surgical
- AlloSource
- Cerapedics Inc
- Keystone Dental Inc
- Xtant Medical Holdings Inc
- Hans Biomed Co Ltd
- Bone Biologics Corp
- SeaSpine Holdings Corporation
- Orthofix Medical Inc
- LifeNet Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.2 Billion |
| Forecasted Market Value ( USD | $ 1.52 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
